Back

Clinical Mic Drop: Eye-Opening Insights Into Neuromodulation for Dry Eye Disease

Despite the availability of numerous therapies for dry eye disease (DED), many treatments fail to fully address the underlying dysfunction of the lacrimal functional unit, leaving patients with suboptimal outcomes and persistent symptom burden. Recent advances in understanding ocular surface pathophysiology have led to the development of neuromodulatory therapies, an innovative approach that targets the neural pathways regulating tear production. How familiar are you with neuromodulation in DED and the latest data supporting its use? Join this Clinical Mic Drop, where a DED expert reviews pivotal clinical trial data from the latest publications and medical conference presentations on neuromodulation in DED.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsOptometryUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Oct 17, 2025
  • Last day to claim credit
    Oct 17, 2026 6 days left